Best Pharma Consulting company

 Nesina (Alogliptin) is an anti-diabetic drug that can be used as an aid to diet and exercise to improve blood sugar control in adults with type 2 diabetes. Nesina should not be used in patients with type 1 diabetes or to treat diabetic ketoacidosis. Common side effects of Nesina include:

Cold symptoms (stuffy nose, sore throat, sinus infection, sinus pain), or

headache.

pharma consulting company

Tell your doctor if you have serious side effects of Nessna, including:

The severe pain in the upper abdomen spreads to the back,

  • Nausea and vomiting,
  • Loss of appetite,
  • Rapid heartbeat,
  • Itching,
  • Black urine
  • Clay stool
  • Jaundice (yellowing of the skin or eyes), or
  • Severe skin reaction.


    pharma consulting company

The recommended dose of Nesina is 25 mg per day. Nesina may interact with other drugs. Tell your doctor about all medicines and supplements you use. Before taking Nesina, tell your doctor if you are pregnant or plan to become pregnant. Whether the drug passes into breast milk is unclear. Consult your doctor before breastfeeding.

Our Nesina (Alogliptin) Side Effects Drug Center provides a comprehensive view of available drug information about potential drug side effects while taking this drug.

If you have signs of an allergic reaction (hives, difficulty breathing, swelling of the face or throat) or severe skin reactions (fever, sore throat, burning eyes, skin pain, red or purple rash, blistering and redness), please Seek emergency medical help. Peeling).

If you have symptoms of pancreatitis, stop taking alogliptin and call your doctor immediately: severe pain in your upper abdomen spreads to your back, nausea and vomiting, loss of appetite or rapid heartbeat.

If you have the following conditions, please call your doctor immediately:

Severe or persistent joint pain;

Heart problems-shortness of breath (even when lying down), rapid weight gain, swelling (especially feet, legs or central area);

Liver problems-nausea, upper abdomen pain, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or

Severe autoimmune reaction-itching, blisters, rupture of the outer layer of the skin.

Common side effects may include:

Headache; or

Cold symptoms such as stuffy nose, sinus pain, sore throat.

It is very challenging to find a good pharma consulting company which is rapidly growing with remarkable note, but there are some companies that provides numerous amount of pharmaceutical consulting services



Comments

Post a Comment

Popular posts from this blog

Best Pharma Consulting Company

Image
 Drug Name Atriance 5 mg/ml infusion solution 2. Qualitative and quantitative composition Each milliliter of solution contains 5 mg of Nelarabine. Each vial contains 250 mg of Nelarabine. Excipients with known effects Each milliliter of solution contains 1.770 mg (77 micromoles) of sodium. For a complete list of excipients, see section 6.1. 3. Drug form Infusion solution. Clear colorless solution. 4. Clinical details 4.1 Treatment indications Nelarabine is suitable for the treatment of patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) who have not responded or relapsed after treatment with at least two chemotherapy regimens. Because the number of patients in these conditions is small, the information supporting these indications is based on limited data. 4.2 Modes and methods of administration Nelarabine can only be administered under the guidance of a doctor who has experience in the use of cytotoxic agents. Ontology The complete b...
Read more

Best Pharma Consulting Company

Image
  Indications Instruct VENCLEXTA: For the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Combine with azacitidine, decitabine or low-dose cytarabine for the treatment of newly diagnosed adult acute myeloid leukemia (AML): 75 years or older, or Patients with comorbidities cannot use intensive induction chemotherapy. Important safety information Contraindications In patients with CLL/SLL, simultaneous use of VENCLEXTA with strong CYP3A inhibitors is contraindicated because it may increase the risk of tumor lysis syndrome (TLS). Tumor lysis syndrome Patients treated with VENCLEXTA developed tumor lysis syndromes, including fatal events and renal failure requiring dialysis. VENCLEXTA can cause rapid tumor reduction, so in all CLL/SLL patients, there is a risk of TLS during the start and the start phase, and during the restart period after the dose is interrupted. Changes in blood chemistry consistent with TLS need to be dealt wi...
Read more

Best Pharma Consulting Company

Image
  About Veenat 400 mg tablets 10 Veenat 400 mg tablets belong to a class of drugs called "anti-cancer drugs" and are mainly used to treat various types of cancer. It is used to treat blood cancers (chronic myeloid leukemia and acute lymphocytic leukemia) and gastrointestinal stromal tumors. Cancer is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues. There are more than 100 kinds of cancer, including blood cancer, lung cancer, breast cancer and so on. 10 Veenat 400 mg tablets contain imatinib, which is mainly used to treat cancer. It works by inhibiting the enzymes responsible for the proliferation of cancer cells and induces cell death (apoptosis). As a result, the growth and spread of cancer cells stopped or slowed down. Take 10 Veenat 400 mg tablets as prescribed by your doctor. It is recommended that you take 10 Veenat 400 mg tablets according to your doctor's condition, as long as your doctor has prescribed it for you. In s...
Read more